3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
40
Gastrointestinal
18
Breast
15
Thoracic
14
Head & Neck
7
Genitourinary
6
Dermatologic
6
Sarcoma
5
Plasma cell
4
Other solid neoplasm
4
CNS
3
Endocrine
2
Other hematologic neoplasm
1
NET
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
147
Leukemia, Lymphocytic, Chronic, B-Cell
140
Lymphoma
116
Lymphoma, Non-Hodgkin
112
Leukemia, Myeloid, Acute
95
Leukemia
92
Myelodysplastic Syndromes
90
Hodgkin Disease
68
Lymphoma, B-Cell
61
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
53
Multiple Myeloma
52
Lymphoma, Mantle-Cell
52
Lymphoma, Large B-Cell, Diffuse
50
Lymphoma, Follicular
50
Recurrence
43
Burkitt Lymphoma
41
Hematologic Neoplasms
36
Myeloproliferative Disorders
31
Lymphoma, B-Cell, Marginal Zone
30
Neoplasms, Plasma Cell
20
Primary Myelofibrosis
19
Leukemia, Biphenotypic, Acute
18
Anemia, Refractory, with Excess of Blasts
18
Lymphoma, T-Cell
17
Leukemia, Myelomonocytic, Chronic
15
Graft vs Host Disease
15
Anemia, Aplastic
15
Leukemia, Prolymphocytic
14
Neoplasms
12
Leukemia, B-Cell
12
Interventions
pembrolizumab
6
Paclitaxel
4
Cyclophosphamide
4
Psychiatric Rehabilitation
3
Flow Cytometry
3
Filgrastim
3
Drug Therapy
3
Carboplatin
3
valspodar
2
trametinib
2
sargramostim
2
epacadostat
2
dabrafenib
2
X-Rays
2
Specimen Handling
2
Nivolumab
2
Microarray Analysis
2
Methylprednisolone
2
Melphalan
2
Injections
2
Immunologic Techniques
2
Gemcitabine
2
Dexamethasone
2
Dasatinib
2
Biopsy
2
Azacitidine
2
Analgesia
2
Amifostine
2
Alemtuzumab
2
vocimagene amiretrorepvec
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
fludarabine
×
Lymphoid
×
Clear all
NCT07410494
2026-02-18
SELECT-CAR-NK
Essen Biotech
Phase 1/2
Recruiting
85 enrolled